Distinguishing LS colorectal cancers that show loss of MLH1 expression from sporadic MMR-deficient cancers is currently most appropriately performed by detection of the specific mutation BRAF V600E, which is found in around 80–90 % of sporadic MSI-H colorectal cancers, but rarely—if ever—in colorectal cancers due to Lynch syndrome [6, 27–31]. Here, BRAF is linked to cancer.